Literature DB >> 28765173

A2A adenosine receptors control pancreatic dysfunction in high-fat-diet-induced obesity.

Balázs Csóka1,2, Gábor Törő3,2, Joana Vindeirinho3, Zoltán V Varga4, Balázs Koscsó5, Zoltán H Németh3,6, Endre Kókai7, Luca Antonioli8, Mara Suleiman8, Piero Marchetti8, Karolina Cseri7, Ádám Deák9, László Virág7,10, Pál Pacher4, Péter Bai7,10, György Haskó11,2,7.   

Abstract

Adenosine, a key extracellular signaling mediator, regulates several aspects of metabolism by activating 4 G-protein-coupled receptors, the A1, A2A, A2B, and A3 adenosine receptors (ARs). The role of A2AARs in regulating high-fat-diet (HFD)-induced metabolic derangements is unknown. To evaluate the role of A2AARs in regulating glucose and insulin homeostasis in obesity, we fed A2AAR-knockout (KO) and control mice an HFD for 16 wk to initiate HFD-induced metabolic disorder. We found that genetic deletion of A2AARs caused impaired glucose tolerance in mice fed an HFD. This impaired glucose tolerance was caused by a decrease in insulin secretion but not in insulin sensitivity. Islet size and insulin content in pancreata of A2AAR-deficient mice were decreased compared with control mice after consuming an HFD. A2AAR-KO mice had decreased expression of the β-cell-specific markers pdx1, glut2, mafA, and nkx6.1 and increased expression of the dedifferentiation markers sox2 and hes1. Ex vivo islet experiments confirmed the role of A2AARs in protecting against decreased insulin content and release caused by HFD. Other experiments with bone marrow chimeras revealed that inflammation was not the primary cause of decreased insulin secretion in A2AAR-KO mice. Altogether, our data showed that A2AARs control pancreatic dysfunction in HFD-induced obesity.-Csóka, B., Törő, G., Vindeirinho, J., Varga, Z. V., Koscsó, B., Németh, Z. H., Kókai, E., Antonioli, L., Suleiman, M., Marchetti, P., Cseri, K., Deák, Á., Virág, L., Pacher, P., Bai, P., Haskó, G. A2A adenosine receptors control pancreatic dysfunction in high-fat-diet-induced obesity. © FASEB.

Entities:  

Keywords:  diabetes; islet; β-cell; β-cell dedifferentiation

Mesh:

Substances:

Year:  2017        PMID: 28765173      PMCID: PMC5636705          DOI: 10.1096/fj.201700398R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  64 in total

Review 1.  Structure and function of adenosine receptors and their genes.

Authors:  B B Fredholm; G Arslan; L Halldner; B Kull; G Schulte; W Wasserman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2000-11       Impact factor: 3.000

2.  Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans.

Authors:  Saverio Cinti; Grant Mitchell; Giorgio Barbatelli; Incoronata Murano; Enzo Ceresi; Emanuela Faloia; Shupei Wang; Melanie Fortier; Andrew S Greenberg; Martin S Obin
Journal:  J Lipid Res       Date:  2005-09-08       Impact factor: 5.922

Review 3.  Glucolipotoxicity: fuel excess and beta-cell dysfunction.

Authors:  Vincent Poitout; R Paul Robertson
Journal:  Endocr Rev       Date:  2007-11-29       Impact factor: 19.871

4.  Hypoxia-inducible factor-1α-dependent protection from intestinal ischemia/reperfusion injury involves ecto-5'-nucleotidase (CD73) and the A2B adenosine receptor.

Authors:  Melanie L Hart; Almut Grenz; Iris C Gorzolla; Jens Schittenhelm; Julee H Dalton; Holger K Eltzschig
Journal:  J Immunol       Date:  2011-02-28       Impact factor: 5.422

Review 5.  Hostile, hypoxia-A2-adenosinergic tumor biology as the next barrier to overcome for tumor immunologists.

Authors:  Michail V Sitkovsky; Stephen Hatfield; Robert Abbott; Bryan Belikoff; Dmitriy Lukashev; Akio Ohta
Journal:  Cancer Immunol Res       Date:  2014-07       Impact factor: 11.151

6.  Diabetes-induced alterations of adenosine receptors expression level in rat liver.

Authors:  Marzena Grden; Marzena Podgorska; Andrzej Szutowicz; Tadeusz Pawelczyk
Journal:  Exp Mol Pathol       Date:  2007-04-04       Impact factor: 3.362

7.  An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors.

Authors:  Grace Pinhal-Enfield; Madhuri Ramanathan; Gyorgy Hasko; Stefanie N Vogel; Andrew L Salzman; Geert-Jan Boons; S Joseph Leibovich
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

8.  Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid.

Authors:  Alexandra E Butler; Juliette Janson; Walter C Soeller; Peter C Butler
Journal:  Diabetes       Date:  2003-09       Impact factor: 9.461

9.  Pancreatic β cell dedifferentiation as a mechanism of diabetic β cell failure.

Authors:  Chutima Talchai; Shouhong Xuan; Hua V Lin; Lori Sussel; Domenico Accili
Journal:  Cell       Date:  2012-09-14       Impact factor: 41.582

10.  Adenosine, adenosine receptors and their role in glucose homeostasis and lipid metabolism.

Authors:  Milka Koupenova; Katya Ravid
Journal:  J Cell Physiol       Date:  2013-03-04       Impact factor: 6.384

View more
  11 in total

1.  Regulation of adipose tissue inflammation by adenosine 2A receptor in obese mice.

Authors:  Ya Pei; Honggui Li; Yuli Cai; Jing Zhou; Xianjun Luo; Linqiang Ma; Kelly McDaniel; Tianshu Zeng; Yanming Chen; Xiaoxian Qian; Yuqing Huo; Shannon Glaser; Fanyin Meng; Gianfranco Alpini; Lulu Chen; Chaodong Wu
Journal:  J Endocrinol       Date:  2018-12-01       Impact factor: 4.286

Review 2.  The adenosine pathway in immuno-oncology.

Authors:  Bertrand Allard; David Allard; Laurence Buisseret; John Stagg
Journal:  Nat Rev Clin Oncol       Date:  2020-06-08       Impact factor: 66.675

3.  Mice lacking adenosine 2A receptor reveal increased severity of MCD-induced NASH.

Authors:  Jing Zhou; Honggui Li; Yuli Cai; Linqiang Ma; Destiny Mathews; Bangchao Lu; Bilian Zhu; Yanming Chen; Xiaoxian Qian; Xiaoqiu Xiao; Qifu Li; Shaodong Guo; Yuqing Huo; Liang Zhao; Yanan Tian; Qingsheng Li; Chaodong Wu
Journal:  J Endocrinol       Date:  2019-09-01       Impact factor: 4.286

4.  KD-64-A new selective A2A adenosine receptor antagonist has anti-inflammatory activity but contrary to the non-selective antagonist-Caffeine does not reduce diet-induced obesity in mice.

Authors:  Magdalena Kotańska; Anna Dziubina; Małgorzata Szafarz; Kamil Mika; Karolina Reguła; Marek Bednarski; Małgorzata Zygmunt; Anna Drabczyńska; Jacek Sapa; Katarzyna Kieć-Kononowicz
Journal:  PLoS One       Date:  2020-06-18       Impact factor: 3.240

Review 5.  Therapeutic potentials of agonist and antagonist of adenosine receptors in type 2 diabetes.

Authors:  Olakunle Sanni; G Terre'Blanche
Journal:  Rev Endocr Metab Disord       Date:  2021-06-24       Impact factor: 6.514

6.  Hypoxia enhances indoleamine 2,3-dioxygenase production in dendritic cells.

Authors:  Xiang Song; Yan Zhang; Li Zhang; Wengang Song; Lixin Shi
Journal:  Oncotarget       Date:  2018-01-09

Review 7.  Purinergic Receptors in Neurological Diseases With Motor Symptoms: Targets for Therapy.

Authors:  Ágatha Oliveira-Giacomelli; Yahaira Naaldijk; Laura Sardá-Arroyo; Maria C B Gonçalves; Juliana Corrêa-Velloso; Micheli M Pillat; Héllio D N de Souza; Henning Ulrich
Journal:  Front Pharmacol       Date:  2018-04-10       Impact factor: 5.810

Review 8.  Inflammatory Links Between High Fat Diets and Diseases.

Authors:  Yehui Duan; Liming Zeng; Changbing Zheng; Bo Song; Fengna Li; Xiangfeng Kong; Kang Xu
Journal:  Front Immunol       Date:  2018-11-13       Impact factor: 7.561

9.  A3 receptor agonist, Cl-IBMECA, potentiate glucose-induced insulin secretion from MIN6 insulinoma cells possibly through transient Ca2+ entry.

Authors:  Mohammad Keyvanloo Shahrestanaki; Mahmoud Aghaei
Journal:  Res Pharm Sci       Date:  2019-03-08

Review 10.  Purinergic Signalling in Parkinson's Disease: A Multi-target System to Combat Neurodegeneration.

Authors:  Adrián Tóth; Zsófia Antal; Dániel Bereczki; Beáta Sperlágh
Journal:  Neurochem Res       Date:  2019-05-04       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.